The fallacy of enrolling only high-risk subjects in cancer prevention trials: Is there a "free lunch"?
<p>Abstract</p> <p>Background</p> <p>There is a common belief that most cancer prevention trials should be restricted to high-risk subjects in order to increase statistical power. This strategy is appropriate if the ultimate target population is subjects at the same hig...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-10-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/4/24 |